Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like Merck KGaA, Pfizer's Lung Cancer Drug Flunks Late-Stage Trial February 15, 2018 OMEICOS Therapeutics Secures Extension Of Series B Financing Round To Expand Its Technology Into Ophthalmology October 4, 2017 LAM Therapeutics Scores $58 Million and a New Clinical Program in Cancer March 29, 2017
OMEICOS Therapeutics Secures Extension Of Series B Financing Round To Expand Its Technology Into Ophthalmology October 4, 2017